FDA has shared information about a contaminated ingredient—organic whole milk powder—in the multistate outbreak of infant botulism associated with ByHeart powdered infant formula.
Researchers estimate that the use of whole genome sequencing (WGS) for routine pathogen surveillance in Australia prevents up to 10,900 foodborne salmonellosis cases and delivers as much as $17 million in cost savings annually.
Nestlé says that cereulide, the contaminant behind the recall, does not cause meningitis, the illness for which the infant was hospitalized. UK authorities say no cases of illness associated with Nestlé formula have been clinically confirmed.
A new analysis of global foodborne illness data revealed that, since 1990, the number of invasive non-typhoidal Salmonella cases and deaths have risen by 46 percent and 27 percent, respectively—with significant regional disparities.
A new study estimates the annual cost of foodborne illness in Australia from six important pathogens to be $721 million AUD, with nearly half of this cost ($328 million AUD) attributed to poultry sources.
In this bonus episode of Food Safety Matters, we speak to four seasoned professionals with experience in the regulatory, academic, and industry spheres about the increasing rate of U.S. food recalls and how the foodborne illness outbreak investigation system could be improved.
U.S. Senator Bill Cassidy, Chair of the HELP Committee, has written a letter to ByHeart Inc., the infant formula manufacturer linked to an ongoing botulism outbreak, demanding answers about the conditions that led to the sale of unsafe product.
The recently updated Cost Estimates of Foodborne Illness data from USDA break down the total estimated cost of foodborne illnesses per case and per pathogen.
In a retrospective analysis of two Listeria monocytogenes outbreaks linked to packaged salads, CDC epidemiologists underline key learnings and suggest proactive measures for industry.
As of December 10, a total of 51 infants are included in the ByHeart formula botulism outbreak. With an expanded case definition, CDC has identified cases that occurred as early as December 2023.
